<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl3">
 <label>Table III</label>
 <caption>
  <p>Examples of partnerships leveraged to collectively combat COVID-19.</p>
 </caption>
 <alt-text id="alttext0055">Table III</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Partnership</th>
    <th>Description</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Access to COVID-19 Tools (ACT) Accelerator</td>
    <td>Pools together various stakeholders (governments, businesses, civil society, and international actors) to support in the development and equitable distribution of medicinal products to lower mortality and severe COVID-19 cases.
     <xref rid="bib5" ref-type="bibr">
      <sup>5</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td>COVID-19 Therapeutics Accelerator</td>
    <td>Launched by the Bill &amp; Melinda Gates Foundation, Wellcome, and Mastercard, this platform aims to support the acceleration and evaluation of new and repurposed medicines and vaccines to treat patients with COVID-19, and ensure equitable access by making these available and affordable notably in low-resource settings.
     <xref rid="bib40" ref-type="bibr">
      <sup>40</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td>International Coalition of Medicines Regulatory Authorities (ICMRA)</td>
    <td>Serves as a forum for strategic co-ordination and international cooperation across regulatory authorities. In lieu of the COVID-19 pandemic, ICMRA members have aimed to expedite and streamline the research, development, and access of COVID-19 treatments and vaccines and ensure the effective and efficient approach to regulatory processes and decisions.
     <xref rid="bib41" ref-type="bibr">
      <sup>41</sup>
     </xref>
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
